Patent · US Active

Method of accelerated vaccination against Ebola viruses

US8017130B2 · kind B2 · utility

1Cited by

3References

9Claims

0Family size

Assignee

The United States of America, as represented by the Department of Health and Human Services · US

Inventors

Gary J. Nabel · Cambridge, US
Nancy Sullivan · Kensington, US
Thomas W. Geisbert · Albany, US
Peter Jahrling · Middletown, US

Key dates

Filing date	Nov 5, 2009
Grant date	Sep 13, 2011
Priority date	—
Expiry date	Nov 5, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to genetic vaccines for stimulating cellular and humoral immune responses in humans and other hosts, and, in particular, relates to recombinant viruses that express heterologous antigens of pathogenic viruses, in single dose form.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.